top of page

ULTIBRO BREEZHALER INHALATION POWDER HARD CAPSULE 110/50 MCG

Product details

Registration number: SIN14539P

Classification: Prescription Only

Active ingredients:

  • Glycopyrronium Bromide 63mcg eqv Glycopyrronium
  • Indacaterol maleate 143mcg eqv Indacaterol (micronized)

Strength:

  • 50 mcg
  • 110 mcg

Dosage form: CAPSULE

Route: BUCCAL

Registrant: NOVARTIS (SINGAPORE) PTE LTD

ATC code: Not availabl

HSA approval date: 10 April 2014

Manufacturer(s):

  • Novartis Pharma Stein AG (blending and co-micronization of NVA237 PI)
  • Novartis Pharma Schweizerhalle AG (all steps of NVA237 PI)
  • Siegfried Barberá S.L.

Manufacturing country/countries: SWITZERLAND; SPAIN

What are the HSA registration number and classification for ULTIBRO BREEZHALER INHALATION POWDER HARD CAPSULE 110/50 MCG?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN14539P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for ULTIBRO BREEZHALER INHALATION POWDER HARD CAPSULE 110/50 MCG?

According to the HSA dataset updated 7 August 2026:

Active ingredients:

  • Glycopyrronium Bromide 63mcg eqv Glycopyrronium
  • Indacaterol maleate 143mcg eqv Indacaterol (micronized)

Strength:

  • 50 mcg
  • 110 mcg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for ULTIBRO BREEZHALER INHALATION POWDER HARD CAPSULE 110/50 MCG?

According to the HSA dataset updated 7 August 2026:

Dosage form: CAPSULE

Route: BUCCAL

Source for this answer

Who is the recorded registrant for ULTIBRO BREEZHALER INHALATION POWDER HARD CAPSULE 110/50 MCG?

According to the HSA dataset updated 7 August 2026:

Registrant: NOVARTIS (SINGAPORE) PTE LTD

Source for this answer

Which manufacturers and countries are listed for ULTIBRO BREEZHALER INHALATION POWDER HARD CAPSULE 110/50 MCG?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • Novartis Pharma Stein AG (blending and co-micronization of NVA237 PI)
  • Novartis Pharma Schweizerhalle AG (all steps of NVA237 PI)
  • Siegfried Barberá S.L.

Manufacturing country/countries: SWITZERLAND; SPAIN

Source for this answer

Where can I look up ULTIBRO BREEZHALER INHALATION POWDER HARD CAPSULE 110/50 MCG in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN14539P or the exact product name ULTIBRO BREEZHALER INHALATION POWDER HARD CAPSULE 110/50 MCG. The general register link does not preselect this product.

Source for this answer

What are the source dates for this ULTIBRO BREEZHALER INHALATION POWDER HARD CAPSULE 110/50 MCG record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this ULTIBRO BREEZHALER INHALATION POWDER HARD CAPSULE 110/50 MCG record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN14539P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page